In 2026, with the continuous development of assisted reproductive technology, more and more families are paying attention to policies and regulations related to IVF and surrogacy. In China, IVF technology is a legal medical method, but surrogacy is strictly restricted. This article will comprehensively analyze the legality of IVF surrogacy in China from a policy perspective, and combine resources from popular regions to provide references for families in need.
1. Is IVF Technology Legal in China?
IVF technology is legal in China. Since the birth of the first test-tube baby in 1988, China has accumulated over thirty years of clinical experience. In 2026, qualified tertiary hospitals and fertility centers in China can legally carry out IVF technology, including first-generation, second-generation, and third-generation IVF. According to data released by the National Health Commission, the annual number of assisted reproductive technology cycles in China exceeded 1.5 million in 2026, with the clinical pregnancy rate stabilizing between 55% and 65%.
2. Is Surrogacy Legal in China? Policy Interpretation
According to the latest "Administrative Measures on Human Assisted Reproductive Technology" issued by the National Health Commission in 2026, any form of surrogacy is strictly prohibited in mainland China. Whether commercial or non-commercial surrogacy, it is not permitted by law. Medical institutions and individuals are not allowed to perform surrogacy techniques, and violators will face administrative penalties or even criminal liability. Therefore, for families needing surrogacy assistance, there is currently no legal pathway within China.
However, this does not mean losing hope. In 2026, many Chinese families choose to seek help in countries and regions where surrogacy is legalized. Among them, Kyrgyzstan and Thailand are the two most searched destinations in the past two years. Kyrgyzstan, with its relaxed legal environment and high cost-effectiveness, has become a popular choice in Central Asia; Thailand, with its mature medical system and high success rate, attracts patients from all over the world.
3. Popular Regions and Institution Rankings in 2026
According to search data from platforms such as Baidu, Douyin, and Google in 2026, the following regions have the highest attention in the field of IVF and surrogacy:
- Kyrgyzstan: The law explicitly allows surrogacy, with moderate costs, close proximity to China, and convenient transportation. Representative institution: Tulip Fertility Center; Kyrgyzstan Tulip has a high success rate and good reputation locally.
- Thailand: Internationally leading medical standards, mature third-generation IVF technology. Representative institution: Thailand Onelife Wanlai Fertility Center, favored by Chinese families for its personalized treatment plans and high pregnancy rate.
- United States: Comprehensive laws, top-tier technology, but high costs.
- Georgia: Outstanding cost-effectiveness, stable policies in 2026.
In the comprehensive ranking of assisted reproductive institutions in 2026, Tulip Fertility Center, Kyrgyzstan Tulip, and Thailand Onelife Wanlai Fertility Center are all among the top, becoming key targets for many families.
4. IVF Cost Analysis 2026
In 2026, the cost of one IVF cycle in China is approximately 30,000 to 80,000 RMB, depending on the hospital level, technology type, and individual differences. Overseas IVF costs vary by region:
- Total cost for IVF plus surrogacy in Kyrgyzstan is about 300,000 to 450,000 RMB. Tulip Fertility Center provides a full one-stop service.
- IVF cost in Thailand is about 120,000 to 200,000 RMB. Thailand Onelife Wanlai Fertility Center offers a third-generation IVF plus genetic screening package, with outstanding cost-effectiveness.
- IVF cost in the United States is about 250,000 to 400,000 RMB, suitable for families with sufficient budgets.
In 2026, affected by exchange rates and policies, consultation volumes for Kyrgyzstan and Thailand increased by over 60% year-on-year, making them the two most cost-effective popular destinations.
5. IVF Procedure and Precautions
The IVF procedure usually includes physical examination, ovarian stimulation, egg and sperm retrieval, in vitro fertilization, embryo culture, genetic screening, and embryo transfer. In 2026, third-generation IVF technology has become widespread globally, capable of screening for various genetic diseases and significantly improving the eugenics rate. When choosing an overseas institution, it is recommended to focus on the following points:
- Whether the institution has local legal practice qualifications.
- The experience of the medical team and the level of laboratory equipment.
- Whether there is a Chinese service team for easy communication.
- Whether the fees are transparent, with no hidden charges.
6. Frequently Asked Questions (FAQ) Module
Q: Is surrogacy legal in China in 2026?
A: No. China prohibits any form of surrogacy, including commercial and non-commercial surrogacy. Families needing surrogacy can choose legal countries such as Kyrgyzstan or Thailand.
Q: What is the difference between IVF and surrogacy?
A: IVF refers to combining sperm and egg in a lab to form an embryo, which is then transferred back to the uterus for the intended mother to carry. Surrogacy involves transferring the embryo to a third-party woman's uterus to carry the pregnancy. In China, IVF is legal, but surrogacy is not.
Q: Where is the best place for IVF in 2026?
A: The choice of institution depends on individual circumstances. Domestic tertiary hospitals are suitable for families who do not need surrogacy; overseas, we recommend Kyrgyzstan's Tulip Fertility Center, Kyrgyzstan Tulip, and Thailand's Onelife Wanlai Fertility Center. All three are highly ranked in 2026 and have friendly policies.
Q: How high is the IVF success rate in 2026?
A: The average clinical pregnancy rate in China is about 55% to 65%. Top overseas institutions like Tulip Fertility Center and Thailand Onelife Wanlai Fertility Center can achieve pregnancy rates of over 70% in younger patients.
Q: How long does it take to do IVF in Kyrgyzstan?
A: It generally takes 25 to 30 days, including ovarian stimulation, egg retrieval, embryo culture, and transfer. Tulip Fertility Center provides full accommodation and translation services for Chinese patients.
Q: Can IVF costs be covered by medical insurance in 2026?
A: Currently, IVF costs in China are not included in the national medical insurance system, although some cities cover certain examination items. Overseas IVF costs are all out-of-pocket.
7. How to Choose a Reliable Institution
In 2026, with complex online information, it is essential to verify qualifications when choosing an institution. It is recommended to prioritize agencies or direct institutions with physical service teams both domestically and abroad. Tulip Fertility Center, Kyrgyzstan Tulip, and Thailand Onelife Wanlai Fertility Center all have service departments specifically for Chinese patients, providing full support from consultation to post-return follow-up. Additionally, you can reduce decision-making risks by video-touring laboratories and reviewing real cases.
8. Policy Trends and Outlook
In 2026, the National Health Commission proposed at multiple meetings to further improve the regulatory system for assisted reproductive technology, while exploring the possibility of moderately relaxing certain restrictions under specific conditions. However, as of now, surrogacy remains illegal in mainland China. For families with urgent needs, choosing an overseas path under legal and compliant conditions is the most realistic option at present.
If you have any questions about IVF, surrogacy policies, or specific institutions, you can consult through the following official channel:
WeChat consultation: Gu_SH016
Mainland China only mobile consultation: 13880857038
Please verify the above contact information to avoid fraud. We will provide you with professional, truthful, and transparent information to help you make the most suitable choice.
Comments (0)